阿拉丁(688179.SH):擬購買上海張江科技園區伽利略路11號7幢
格隆匯 2 月 8日丨阿拉丁(688179.SH)公佈,公司擬與上海奕臻化工工程技術有限公司公司簽訂《商品房買賣合同》,購買位於上海張江科技園區伽利略路11號7幢。該房產建築面積1311.82平方米(地上三層,地下一層),交易價格為人民幣4000萬元。
交易標的公司將用來籌建實驗室,用於生物試劑的研究開發。交易標的交付後將會增加公司的固定資產規模,未來將相應增加折舊費用及相關税費,減少租賃費用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.